The Efficacy and Safety of Ezetimibe and Low-Dose Simvastatin as a Primary Treatment for Dyslipidemia in Renal Transplant Recipients
Hye Eun Yoon, Joon Chang Song, Bok Jin Hyoung, Hyeon Seok Hwang, So Young Lee, Youn Joo Jeon, Bum Soon Choi, Yong Soo Kim, Chul Woo Yang
Korean J Intern Med. 2009;24(3):233-237.   Published online 2009 Aug 26     DOI:
Citations to this article as recorded by Crossref logo
Ezetimibe – a new approach in hypercholesterolemia management
Dariusz Suchy, Krzysztof Łabuzek, Antoni Stadnicki, Bogusław Okopień
Pharmacological Reports.2011; 63(6): 1335.     CrossRef
Lipid-lowering effects of ezetimibe and simvastatin in combination
Nkechinyere Ijioma, Jennifer G Robinson
Expert Review of Cardiovascular Therapy.2011; 9(2): 131.     CrossRef
Comparison of Clinical Outcomes of Hydrophilic and Lipophilic Statins in Patients with Acute Myocardial Infarction
Min Chul Kim, Youngkeun Ahn, Su Young Jang, Kyung Hoon Cho, Seung Hwan Hwang, Min Goo Lee, Jum Suk Ko, Keun Ho Park, Doo Sun Sim, Nam Sik Yoon, Hyun Ju Yoon, Kye Hun Kim, Young Joon Hong, Hyung Wook Park, Ju Han Kim, Myung Ho Jeong, Jeong Gwan Cho, Jong C
The Korean Journal of Internal Medicine.2011; 26(3): 294.     CrossRef
Ezetimibe in diabetes: more than cholesterol lowering?
Maria Sarigianni, Niki Katsiki, Dimitri P Mikhailidis
Current Medical Research and Opinion.2010; 26(10): 2517.     CrossRef
Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events
M. H. Ahmed, C. D. Byrne
Diabetes, Obesity and Metabolism.2010; 12(11): 958.     CrossRef